CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Consecutive versus concomitant follicle-stimulating hormone and highly purified human menopausal gonadotropin: A milder response but better quality
Hassan Ali Maghraby, Abdel Fattah Mohamed Agameya, Manal Shafik Swelam, Nermeen Ahmed El Dabah, Ola Youssef Ahmed
Clin Exp Reprod Med. 2022;49(2):135-141.   Published online May 30, 2022
DOI: https://doi.org/10.5653/cerm.2021.05155

Excel Download

Consecutive versus concomitant follicle-stimulating hormone and highly purified human menopausal gonadotropin: A milder response but better quality
Hassan Ali El Maghraby, Abdel Fattah Mohamed Agameya, Manal Shafik Swelam, Nermeen Ahmed ElDabah, Ola Youssef Ahmed
Clinical and Experimental Reproductive Medicine. 2022;49(2):135-141   Crossref logo
Link1 Link2 Link3
Economic evaluation of highly purified human menopausal gonadotropin versus recombinant human follicle-stimulating hormone in fresh and frozen in vitro fertilization/intracytoplasmic sperm-injection cycles in Sweden
Jaro Wex, Abou-Setta
ClinicoEconomics and Outcomes Research. 2013;381   Crossref logo
Link1
Gene expression profiles of cumulus cells obtained from women treated with recombinant human luteinizing hormone + recombinant human follicle-stimulating hormone or highly purified human menopausal gonadotropin versus recombinant human follicle-stimulating hormone alone
Valentina Gatta, Carla Tatone, Rosanna Ciriminna, Marilena Vento, Sara Franchi, Marco d'Aurora, Samantha Sperduti, Vito Cela, Placido Borzì, Roberto Palermo, Liborio Stuppia, Paolo Giovanni Artini
Fertility and Sterility. 2013;99(7):2000-2008.e1   Crossref logo
Link1 Link2
A comparison of the efficacy and safety of combined highly purified human menopausal gonadotropin (HP-hMG) and highly purified urinary follicle stimulating hormone (HP-uFSH) versus HP-hMG alone for ovarian stimulation
C.E. Miller, D. Shapiro, C.A. Witz, R. Willey, P.W. Heiser, J. Ruman, V.I. Yankov
Fertility and Sterility. 2015;104(3):e322-e323   Crossref logo
Link1 Link2
Highly purified human menopausal gonadotropin (hMG-HP; Menopur®) versus purified urinary follicle stimulating hormone (Po-FSH; Ovitrop®) for the induction of superovulation in women undergoing assisted reproductive techniques
Gautam Nand Allahbadia, Goral Neeraj Gandhi, Rubina Murtaza Merchant, Kaushal Sameer Kadam, Surender Pal Singh Harbhajan Virk, Kulvinder Mandeep Kaur
Fertility and Sterility. 2002;78:S124   Crossref logo
Link1 Link2
Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization–intracytoplasmic sperm injection patients
Peter G.A. Hompes, Frank J. Broekmans, Diederik A. Hoozemans, Roel Schats
Fertility and Sterility. 2008;89(6):1685-1693   Crossref logo
Link1 Link2
A differential cytokine expression profile is induced by highly purified human menopausal gonadotropin and recombinant follicle-stimulating hormone in a pre- and postovulatory mouse follicle culture model
Rebecca Foster, Ingrid Segers, David Smart, Tom Adriaenssens, Johan Smitz, Joan-Carles Arce, Marc Princivalle
Fertility and Sterility. 2010;93(5):1464-1476   Crossref logo
Link1 Link2
Methodologic pitfalls in assessing the efficacy of recombinant follicle-stimulating hormone versus human menopausal gonadotropin in assisted reproduction
Salim Daya
Fertility and Sterility. 2003;80(5):1100-1104   Crossref logo
Link1 Link2
Results of ovulation induction using human menopausal gonadotropin or purified follicle-stimulating hormone in hypogonadotropic hypogonadism patients
Zeev Shoham, Adam Balen, Anita Patel, Howard S. Jacobs
Fertility and Sterility. 1991;56(6):1048-1053   Crossref logo
Link1 Link2
COST COMPARISON OF HIGHLY PURIFIED HUMAN MENOPAUSAL GONADOTROPIN (HP-HMG) VERSUS RECOMBINANT FOLLICLE-STIMULATING HORMONE (RFSH) FOR CONTROLLED OVARIAN STIMULATION IN US HIGH-RESPONDER PATIENTS BASED ON THE MEGASET-HR TRIAL
Andrew F. Khair, Tray Brown, Marie Markert, Carl H. Samuelsen, Carsten Barsøe, Gaurang S. Daftary, Patrick W. Heiser
Fertility and Sterility. 2021;116(3):e267   Crossref logo
Link1 Link2